Windebank S[au] - Search Results

Year	Number of Results
1993	1
1994	1
1998	1
2008	1
2012	1
2021	1
2022	2
2023	0

1

Next generation risk assessment for skin allergy: Decision making using new approach methodologies.

Gilmour N, Reynolds J, Przybylak K, Aleksic M, Aptula N, Baltazar MT, Cubberley R, Rajagopal R, Reynolds G, Spriggs S, Thorpe C, Windebank S, Maxwell G. Gilmour N, et al. Among authors: windebank s. Regul Toxicol Pharmacol. 2022 Jun;131:105159. doi: 10.1016/j.yrtph.2022.105159. Epub 2022 Mar 17. Regul Toxicol Pharmacol. 2022. PMID: 35311660

2

Decision making in next generation risk assessment for skin allergy: Using historical clinical experience to benchmark risk.

Reynolds J, Gilmour N, Baltazar MT, Reynolds G, Windebank S, Maxwell G. Reynolds J, et al. Among authors: windebank s. Regul Toxicol Pharmacol. 2022 Oct;134:105219. doi: 10.1016/j.yrtph.2022.105219. Epub 2022 Jul 12. Regul Toxicol Pharmacol. 2022. PMID: 35835397 Free article.

3

A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products.

Reynolds G, Reynolds J, Gilmour N, Cubberley R, Spriggs S, Aptula A, Przybylak K, Windebank S, Maxwell G, Baltazar MT. Reynolds G, et al. Among authors: windebank s. Regul Toxicol Pharmacol. 2021 Dec;127:105075. doi: 10.1016/j.yrtph.2021.105075. Epub 2021 Oct 30. Regul Toxicol Pharmacol. 2021. PMID: 34728330 Free article.

4

Absolute oral bioavailability and metabolic turnover of β-sitosterol in healthy subjects.

Duchateau G, Cochrane B, Windebank S, Herudzinska J, Sanghera D, Burian A, Müller M, Zeitlinger M, Lappin G. Duchateau G, et al. Among authors: windebank s. Drug Metab Dispos. 2012 Oct;40(10):2026-30. doi: 10.1124/dmd.112.046623. Epub 2012 Jul 23. Drug Metab Dispos. 2012. PMID: 22826463 Clinical Trial.

5

The ability of the Comet assay to discriminate between genotoxins and cytotoxins.

Henderson L, Wolfreys A, Fedyk J, Bourner C, Windebank S. Henderson L, et al. Among authors: windebank s. Mutagenesis. 1998 Jan;13(1):89-94. doi: 10.1093/mutage/13.1.89. Mutagenesis. 1998. PMID: 9491401

6

Induction of micronuclei in rat bone marrow and peripheral blood following acute and subchronic administration of azathioprine.

Henderson L, Fedyk J, Windebank S, Smith M. Henderson L, et al. Among authors: windebank s. Mutat Res. 1993 Feb;291(1):79-85. doi: 10.1016/0165-1161(93)90019-v. Mutat Res. 1993. PMID: 7678917

7

Photomutagenicity assays in bacteria: factors affecting assay design and assessment of photomutagenic potential of para-aminobenzoic acid.

Henderson L, Fedyk J, Bourner C, Windebank S, Fletcher S, Lovell W. Henderson L, et al. Among authors: windebank s. Mutagenesis. 1994 Sep;9(5):459-65. doi: 10.1093/mutage/9.5.459. Mutagenesis. 1994. PMID: 7837980

8

Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: an enabling study for independent validation as an alternative method.

Billinton N, Hastwell PW, Beerens D, Birrell L, Ellis P, Maskell S, Webster TW, Windebank S, Woestenborghs F, Lynch AM, Scott AD, Tweats DJ, van Gompel J, Rees RW, Walmsley RM. Billinton N, et al. Among authors: windebank s. Mutat Res. 2008 May 31;653(1-2):23-33. doi: 10.1016/j.mrgentox.2008.02.011. Epub 2008 Mar 27. Mutat Res. 2008. PMID: 18450500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results